Literature DB >> 21740657

The social determinants of health: key to global tuberculosis control.

K Rasanathan1, A Sivasankara Kurup1, E Jaramillo2, K Lönnroth2.   

Abstract

Improved tuberculosis (TB) diagnosis and treatment through the DOTS and Stop TB strategies have saved millions of lives; however, their impact on TB incidence has been disappointing and the scale of the epidemic remains overwhelming. To reduce the incidence of TB, the drivers of the epidemic and social determinants of TB need to be addressed. These include co-morbidities and substance use and, moreover, the social and economic conditions that determine both the course of the TB epidemic and exposure to these risk factors. Doing so builds on the history of TB prevention and treatment during the public health revolution that resulted in a dramatic reduction in incidence in many countries. Addressing the social determinants is also imperative to address pervasive inequities in the incidence, mortality and morbidity of TB between different population groups, including in the performance of health systems in delivering diagnostic and treatment interventions, and in the financial consequences of people seeking care. Action on the social determinants can be categorised in terms of health-sector interventions, intersectoral policies impacting across society, and measurement and research to better understand inequities and links between TB and other factors. TB programmes cannot carry out these actions alone; however, they can make important contributions in the delivery of interventions and in advocating and negotiating for intersectoral efforts. The considerable progress seen in the clinical care of TB needs to be sustained; however, the attainment of TB targets, including elimination by 2050, will require expansion of the lens of TB control efforts beyond 'business as usual' to address the social determinants of the disease.

Entities:  

Mesh:

Year:  2011        PMID: 21740657     DOI: 10.5588/ijtld.10.0691

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  40 in total

1.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

2.  The Global Spine Care Initiative: public health and prevention interventions for common spine disorders in low- and middle-income communities.

Authors:  Bart N Green; Claire D Johnson; Scott Haldeman; Edward J Kane; Michael B Clay; Erin A Griffith; Juan M Castellote; Matthew Smuck; Shanmuganathan Rajasekaran; Eric L Hurwitz; Margareta Nordin; Kristi Randhawa; Hainan Yu
Journal:  Eur Spine J       Date:  2018-08-11       Impact factor: 3.134

3.  Housing and tuberculosis in an Inuit village in northern Quebec: a case-control study.

Authors:  Faiz Ahmad Khan; Greg J Fox; Robyn S Lee; Mylene Riva; Andrea Benedetti; Jean-François Proulx; Shelley Jung; Karen Hornby; Marcel A Behr; Dick Menzies
Journal:  CMAJ Open       Date:  2016-09-16

4.  From Exceptional to Liminal Subjects: Reconciling Tensions in the Politics of Tuberculosis and Migration.

Authors:  Jed Horner
Journal:  J Bioeth Inq       Date:  2016-01-12       Impact factor: 1.352

5.  Factors associated with recurrent tuberculosis more than 12 months after treatment completion.

Authors:  L Kim; P K Moonan; C M Heilig; R S Yelk Woodruff; J S Kammerer; M B Haddad
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

6.  Negotiating "The Social" and Managing Tuberculosis in Georgia.

Authors:  Erin Koch
Journal:  J Bioeth Inq       Date:  2016-01-06       Impact factor: 1.352

Review 7.  Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward.

Authors:  C D Acosta; A Dadu; A Ramsay; M Dara
Journal:  Public Health Action       Date:  2014-10-21

8.  Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis.

Authors:  Changtai Zhu; Jinming Liu; Yang Ling; Hua Yang; Zhonghua Liu; Ruijuan Zheng; Lianhua Qin; Zhongyi Hu
Journal:  BMC Infect Dis       Date:  2012-04-20       Impact factor: 3.090

9.  Integrated and patient-selected care facilitates completion of isoniazid preventive therapy in Eswatini.

Authors:  L V Adams; T S B Maseko; E A Talbot; S W Grande; M M Mkhontfo; Z Z Simelane; A A Achilla; S M Haumba
Journal:  Public Health Action       Date:  2019-12-21

Review 10.  Epidemiology of tuberculosis in WHO European Region and public health response.

Authors:  Masoud Dara; Andrei Dadu; Kristin Kremer; Richard Zaleskis; Hans H P Kluge
Journal:  Eur Spine J       Date:  2012-05-08       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.